Deep brain stimulation of the subthalamic nucleus or the internal pallidum can be an effective treatment for the disabling motor complications arising from dopaminergic treatment for Parkinson disease. The subthalamic nucleus has emerged as the preferred target for such treatment; however, no data exist to guide the choice between these two sites.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Functional Connectivity-Based Modelling Simulates Subject-Specific Network Spreading Effects of Focal Brain Stimulation
Neuroscience Bulletin Open Access 24 July 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Foltynie, T. et al. MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety. J. Neurol. Neurosurg. Psychiatry doi:10.1136/jnnp.2010.205542.
Follett, K. A. et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N. Engl. J. Med. 362, 2077–2091 (2010).
Weaver, F. M. et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301, 63–73 (2009).
Krack, P. et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 349, 1925–1934 (2003).
Rodriguez-Oroz, M. C. et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 128, 2240–2249 (2005).
Moro, E. et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov. Disord. 25, 578–586 (2010).
Okun, M. S. et al. Management of referred deep brain stimulation failures. Arch. Neurol. 62, 1250–1255 (2005).
Kleiner-Fisman, G. et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord. 21 (Suppl. 14), S290–S304 (2006).
Vitek, J. L. et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann. Neurol. 53, 558–569 (2003).
Moro, E., Poon, Y. Y., Lozano, A. M., Saint-Cyr, J. A. & Lang, A. E. Subthalamic nucleus stimulation: improvements in outcome with reprogramming. Arch. Neurol. 63, 1266–1272 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
P. Krack has received research support and reimbursement of travel costs to scientific meetings from Medtronic. M. I. Hariz has received honoraria and travel expenses from Medtronic for speaking at meetings.
Rights and permissions
About this article
Cite this article
Krack, P., Hariz, M. Deep brain stimulation in Parkinson disease—what went wrong?. Nat Rev Neurol 6, 535–536 (2010). https://doi.org/10.1038/nrneurol.2010.141
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2010.141
This article is cited by
-
Functional Connectivity-Based Modelling Simulates Subject-Specific Network Spreading Effects of Focal Brain Stimulation
Neuroscience Bulletin (2018)
-
Nucleus subthalamicus ist langfristig der bessere THS-Zielpunkt
InFo Neurologie & Psychiatrie (2016)
-
Der positive Effekt bleibt drei Jahre stabil
InFo Neurologie & Psychiatrie (2012)